Katherine Stanbury

Dr. Katherine Stanbury

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKatherine Stanbury
Katherine Stanbury
RSRenata Stavinohova
Renata Stavinohova
LPLouise Pettitt
Louise Pettitt
CDChris Dixon
Chris Dixon
ESEllen Clare Schofield
Ellen Clare Schofield
CMCathryn S. Mellersh
Cathryn S. Mellersh
Multiocular defect has been described in different canine breeds, including the Old English Sheepdog. Affected dogs typically present with multiple and various ocular abnormalities. We carried out whole genome sequencing on an Old English Sheepdog that had been diagnosed with hereditary cataracts at the age of five and then referred to a board-certified veterinary ophthalmologist due to owner-reported visual deterioration. An ophthalmic assessment revealed that there was bilateral vitreal degeneration, macrophthalmos, and spherophakia in addition to cataracts. Follow-up consultations revealed cataract progression, retinal detachment, uveitis and secondary glaucoma. Whole genome sequence filtered variants private to the case, shared with another Old English Sheepdog genome and predicted to be deleterious were genotyped in an initial cohort of six Old English Sheepdogs (three affected by multiocular defect and three control dogs without evidence of inherited eye disease). Only one of the twenty-two variants segregated correctly with multiocular defect. The variant is a single nucleotide substitution, located in the collagen-type gene COL11A1, c.1775T>C, that causes an amino acid change, p.Phe1592Ser. Genotyping of an additional 14 Old English Sheepdogs affected by multiocular defect revealed a dominant mode of inheritance with four cases heterozygous for the variant. Further genotyping of hereditary cataract-affected Old English Sheepdogs revealed segregation of the variant in eight out of nine dogs. In humans, variants in the COL11A1 gene are associated with Stickler syndrome type II, also dominantly inherited.

20 July 2024 in Genes
Verified
Journal Article
Open access
PDF file
KSKatherine Stanbury
Katherine Stanbury
ESEllen Clare Schofield
Ellen Clare Schofield
BMBryan McLaughlin
Bryan McLaughlin
OFOliver P. Forman
Oliver P. Forman
CMCathryn Mellersh
Cathryn Mellersh
Progressive retinal atrophies (PRAs) are a genetically heterogeneous group of inherited eye diseases that affect over 100 breeds of dog. The initial clinical sign is visual impairment in scotopic conditions, as a consequence of rod photoreceptor cell degeneration. Photopic vision degeneration then follows, due to progression of the disease to the cone photoreceptors, and ultimately results in complete blindness. Two full-sibling English Shepherds were diagnosed with PRA at approximately 5 years old and tested clear of all published PRA genetic variants. This study sought to identify the novel PRA-associated variant segregating in the breed. We utilised a combined approach of whole genome sequencing of the probands and homozygosity mapping of four cases and 22 controls and identified a short interspersed nuclear element within an alternatively spliced exon in FAM161A. The XP_005626197.1 c.17929_ins210 variant was homozygous in six PRA cases and heterozygous or absent in control dogs, consistent with a recessive mode of inheritance. The insertion is predicted to extend exon 4 by 39 aberrant amino acids followed by an early termination stop codon. PRA is intractable to treatment, so the development of a genetic screening test, based on the associated variant, is significant, because it provides dog breeders/owners with a means of reducing the frequency of the disease variant within this breed as well as minimising the risk of breeding puppies that will develop this blinding disease.

28 January 2025 in G3: Genes, Genomes, Genetics
Verified
Journal Article
Open access
JOJames A C Oliver
James A C Oliver
KSKatherine Stanbury
Katherine Stanbury
ESEllen Schofield
Ellen Schofield
BMBryan McLaughlin
Bryan McLaughlin
CMCathryn S Mellersh
Cathryn S Mellersh
Retinopathy with vitamin E deficiency is a familial disease in the English Cocker Spaniel dog breed. Ophthalmic abnormalities observed in retinopathy with vitamin E deficiency-affected English Cocker Spaniel include lipofuscin granule deposition within the tapetal fundus and subsequent retinal degeneration resulting in visual deficits. Affected dogs may also exhibit neurological signs that include ataxia and hindlimb proprioceptive deficits. In all cases, circulating plasma concentrations of α-tocopherol are low. This study sought to investigate the genetic basis of retinopathy with vitamin E deficiency in the English Cocker Spaniel breed. We undertook a genome-wide association study comprising 30 English Cocker Spaniels with normal fundic examinations aged 6 years or older (controls) and 20 diagnosed with retinopathy with vitamin E deficiency (cases) and identified a statistically associated signal on chromosome 29 (Praw = 1.909 × 10−17). Whole genome sequencing of 2 cases identified a 102 bp deletion in exon 1 of the alpha-tocopherol transfer protein gene (TTPA), truncating the protein by 34 amino acids. The c.23_124del variant segregated with retinopathy with vitamin E deficiency in a total of 30 cases and 43 controls. Variants in TTPA are causal for ataxia with vitamin E deficiency in humans which is a phenotypically similar disease to retinopathy with vitamin E deficiency. The identification of the canine variant is extremely significant as the availability of a DNA test will allow for identification of presymptomatic dogs and early therapeutic intervention which may prevent development of retinopathy and improve neurological signs. Breeders can also use the DNA test to efficiently eradicate the disease from this breed.

26 October 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKatherine Stanbury
Katherine Stanbury
MCMaria Paola Cassarani
Maria Paola Cassarani
JBJoseph P. Boyle
Joseph P. Boyle
ESEllen Schofield
Ellen Schofield
BMBryan McLaughlin
Bryan McLaughlin
CMCathryn Mellersh
Cathryn Mellersh
GAPO syndrome is characterised by a core combination of phenotypes: g rowth retardation, a lopecia, p seudoanodontia and o cular atrophy, and to date has only been reported in humans. It is a rare autosomal recessive condition caused by pathogenic variants in the Anthrax Toxin Receptor 1 ( ANTXR1 ) gene. This study reports a canine form of the disease observed in a litter of Segugio Italiano dogs. Affected dogs, examined at 21 months old, presented with the core GAPO phenotype, short limbs, craniofacial abnormalities, alopecia, pseudoanodontia, and ocular abnormalities that included glaucoma. Whole genome sequence analysis of two affected puppies and the dam identified a nonsense variant c.505C > T in ANTXR1 which introduces an early stop codon in exon 7, predicted to truncate the protein by 395 amino acids. Comparative quantification of ANTXR1 gene expression in corneal, retinal and optic nerve tissues of a GAPO-affected dog were markedly reduced compared to control samples. Evaluation of protein expression through Western blot analysis using retinal and optic nerve tissue showed absence of ANTXR1 in the affected dog. Access to canine ocular tissues, rarely available in human GAPO patients, provides insight into tissue-specific effects of ANTXR1 loss. Our findings establish this canine disorder as a model of human GAPO syndrome and has facilitated the development of a DNA test that can identify carriers of the disease variant and prevent production of affected litters with this life limiting disease.